Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
about
The use and misuse of positron emission tomography in lung cancer evaluationRelationship Between Dual-Time Point FDG PET and Immunohistochemical Parameters in Preoperative Colorectal Cancer: Preliminary Study.Dual-time-point FDG PET/CT: Is It Useful for Lymph Node Staging in Patients with Non-Small-Cell Lung Cancer?18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and bUse of ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography in a miniature pig (Sus scrofa domestica) with pneumonia.Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterizationDefining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?Dual-time-point positron emission tomography findings of benign mediastinal fluorine-18-fluorodeoxyglucose uptake in tuberculosis-endemic region.Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients.Relationship Between Dual Time Point FDG PET/CT and Clinical Prognostic Indexes in Patients with High Grade Lymphoma: a Pilot Study.Acquisition time optimization of positron emission tomography studies by use of a regression function derived from torso cross-sections and noise-equivalent counts.Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT.Standardized uptake value differences between primary and metastatic lesions in ¹⁸F-FDG PET/CT of patients with lung cancer.Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region.Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas.Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis.Advanced kinetic modelling strategies: towards adoption in clinical PET imagingLimited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules
P2860
Q27021838-092B2205-6416-4330-90FB-2349A6D84F95Q33704285-8BFA9B3E-02CE-4BF3-89EF-96A4416C5C9CQ33704517-899FBC35-710F-42E6-9988-7828B6EFF8D3Q33823389-40519B8D-BC46-4CE3-94E8-161EFC6C88CCQ36000030-993F4E2F-AC78-4B36-BBF4-C4D0F85C0ADBQ36337401-D8060693-8989-4B07-A760-A94AF5885B67Q36618941-AE2D43BB-CDCA-4E4D-AC17-E42B986A59DDQ37440346-AD89AF38-6622-4553-A947-66D4C3597B10Q37827751-93F68579-E66D-4572-8981-AAEA10CD856AQ38077707-6CAC8760-9381-4FE2-91C6-208DE1864A65Q38568419-91ACF9A9-F81D-42A5-A046-A0538826A614Q40330165-BE2AF8EA-6EE3-497B-9737-C84637AA96EBQ48535641-B25CABC3-70E5-48B1-A6FC-3DEF2068683FQ50729253-CE8954B7-C75C-42BE-A1D9-40B579C270CDQ53026369-C2B0ACBD-5E4B-4A01-85C6-33AC21C4BC81Q53040937-711DC8E9-6FB8-4F26-8576-6A0314D64E68Q53063299-F04784C3-1B5E-4FEA-8817-1EF409B98156Q53090206-5AE72353-6E7D-4D3D-8FB3-5DDA4C26D35AQ53214090-0CC7F7CE-1592-41B9-89C6-6AE56B5D6B69Q53239854-677EAAA0-4906-475D-8CDE-C525670EA2B5Q56835422-04725036-7BBD-4F77-978E-99CE4F911A7BQ57644671-47F0B888-1EBA-406F-A8C0-3A5CACA9A30C
P2860
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
@en
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
@nl
type
label
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
@en
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
@nl
prefLabel
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
@en
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
@nl
P2093
P1476
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
@en
P2093
Daisuke Uesaka
Isamu Miyamori
Masato Sasaki
Shingo Ameshima
Takeshi Ishizaki
Yasuhisa Fujibayashi
Yoshiki Demura
P304
P356
10.2967/JNUMED.108.051250
P407
P577
2008-09-15T00:00:00Z